Marketing and manufacturing practices for compounded GLP-1RA drugs have come under FDA scrutiny, prompting policy changes.

A new study reports that a single dose of psilocybin, quieted chronic pain and depression-like behavior within 24 hours.

Researchers at Ruhr University Bochum, Germany, identified a receptor that plays a crucial role in stress-induced motor ...

GLP-1 drugs such as Ozempic are accelerating interest in protein to address the loss of lean muscle mass that can accompany ...

If you occasionally have trouble falling asleep, taking medications like melatonin or certain antihistamines can help you drift off.

People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems.

New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, ...

Efficacy of tirzepatide does not differ significantly between men and women, despite sex-specific differences in ...

Rare disease drug maker Swedish Orphan Biovitrum (Sobi) said on Friday that its phase 3 study of Avatrombopag had not met its primary endpoint, sending the company's shares sharply down.

This 3-part series looks at the evidence for the treatment of SUDs reviews & the use of GLP-1 receptor agonists and alcohol use disorder.

In this cohort study, 40% of orders for glucagon-like peptide-1 receptor agonists (GLP-1RAs) were not filled. Non-Hispanic Black patients and Hispanic patients were less likely to fill orders than non ...

Myrobalan Therapeutics Nanjing Co. Ltd. has divulged uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-like) antagonists reported to be useful for the treatment of multiple sclerosis, ...